Opinion/decision on a Paediatric investigation plan (PIP): Agamree, Vamorolone, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Other, PIP number: P/0515/2023

Submitted by Anonymous (not verified) on 14 February 2025 - 16:32

Opinion/decision on a Paediatric investigation plan (PIP): Agamree, Vamorolone, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Other, PIP number: P/0515/2023

Opinion/decision on a Paediatric investigation plan (PIP): Olumiant, Baricitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Immune system disorders, PIP number: P/0520/2023

Submitted by Anonymous (not verified) on 14 February 2025 - 16:15

Opinion/decision on a Paediatric investigation plan (PIP): Olumiant, Baricitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Immune system disorders, PIP number: P/0520/2023

Opinion/decision on a Paediatric investigation plan (PIP): Mounjaro, Tirzepatide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Other, PIP number: P/0478/2023

Submitted by Anonymous (not verified) on 14 February 2025 - 16:14

Opinion/decision on a Paediatric investigation plan (PIP): Mounjaro, Tirzepatide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Other, PIP number: P/0478/2023

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More